Ethnic minorities are 'silent sufferers' of chronic fatigue syndrome

A multi-institute study funded by the Medical Research Council (UK), involving researchers across London and Manchester, looked at data from over 4000 adults living in England. The result of this study showed that, on average, there is a 2.3% risk of suffering from CFS and that risk increases with age by 2% per year from the age of 35. When the researchers compared the occurrence of CFS with medical factors and exercise they found that, while both depression and anxiety were associated with a much higher risk of CFS, moderate exercise halved the risk.

Social status and adversity were also major risk factors along with cultural and ethnic background. The incidence of CFS was highest amongst people who had the most difficulties with housing, finances, or had family problems, but this was balanced by levels of support within the community. Perceived cultural discrimination and insults in the workplace, or in society, along with racial and religious discrimination, were also much higher for CFS sufferers. Overall people with Pakistani, Indian or Black Caribbean backgrounds had a greater risk of CFS than the white population.

Professor Bhui from Barts and the London School of Medicine and Dentistry, Queen Mary, University of London said, “Earlier studies, based on attendance at clinics, indicated that CFS is a disease of white, middle class people. Our results show that CFS is more common amongst the physically inactive, those with social difficulties and with poor social support, and ethnic minorities, especially in the Pakistani group studied, and that they are silently suffering.”

Notes to Editors

1. Chronic fatigue syndrome in an ethnically diverse population: the influence of psychosocial adversity & physical inactivity
Kamaldeep S Bhui, Sokratis Dinos, Deborah Ashby, James Nazroo, Simon Wessely, and Peter D White

BMC Medicine (in press)

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication.

2. BMC Medicine – the flagship medical journal of the BMC series – publishes original research articles, commentaries and reviews in all areas of medical science and clinical practice. To be appropriate for BMC Medicine, articles need to be of outstanding quality, broad interest and special importance. BMC Medicine (ISSN 1741-7015) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, EMBASE, Scopus, Current Contents, Thomson Reuters (ISI) and Google Scholar.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.